EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines

Zufa Sabeel, Ruolan Chen, Yan Liu, Xiaoyang Chen, Wenjing Zhang, Shangyang Pan, Lu Ying, Changyuan Yu, Zhao Yang iD

International Journal of Molecular Sciences · 03.04.2026 · 27 (7) · 3251

DOI: 10.3390/ijms27073251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.04.2026. Verfasst von Zufa Sabeel und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science and Technology, State Key Laboratory of Green Biomanufacturing, Innovation Center of Molecular Diagnostics, Beijing Universit…. Hauptthemen laut MEDLINE: Apoptosis, Liver Neoplasms, Carcinoma, Hepatocellular, Hepatoblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major Research Plan of the National Natural Science Foundation of China, National Key Research and Development Program, Open Competition to Select the Best Candidates" Key Technology Program for Nucleic Acid Drugs of NCTIB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer is one of the most prevalent and lethal cancers worldwide, characterized by poor prognosis and limited treatment options. Triptophenolide (TRI), a diterpenoid compound, has shown anti-proliferative activity in breast and pancreatic cancers, but its role in liver cancer remains largely unexplored. In this study, TRI significantly inhibited the proliferation of HepG2 (hepatoblastoma) and HuH7 (hepatocellular carcinoma) cells in a dose-dependent manner, with IC50 values decreasing from 279.9 to 229.4 µg/mL (24–48 h) in HepG2 and from 441.1 to 282.6 µg/mL in HuH7. Colony formation assays confirmed the suppression of HCC cell growth. TRI also promoted apoptosis, increasing apoptotic rates to 68.99% in HepG2 and 43.34% in HuH7 at 400 µg/mL (48 h). Cell cycle analysis revealed S-phase arrest, with TRI raising the S-phase population to 42.02% and 45.38%, respectively. Mechanistically, TRI upregulated pro-apoptotic genes (TP53, CASP3/9/10, BAX, BAK1, BID, BIM) and proteins, activating the mitochondrial apoptotic pathway. In vivo, TRI (10 mg/kg) markedly reduced tumor volumes in HepG2 and HuH7 xenografts compared with controls, without obvious systemic toxicity. These findings suggest that TRI exerts anti-proliferative, pro-apoptotic, and cell cycle regulatory effects in HCC. However, further preclinical studies are warranted to elucidate its mechanisms and evaluate its safety profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisLiver NeoplasmsCarcinoma, HepatocellularHepatoblastomaDiterpenesAntineoplastic AgentsHumansAnimalsCell ProliferationMiceHep G2 CellsXenograft Model Antitumor AssaysCell Line, TumorMice, Nude

Stichwörter der Autor:innen

Triptophenolideantitumor effectapoptosisliver cancerproliferationxenograft model

Substanzen

DiterpenesAntineoplastic Agents

Autor:innen und Institutionen

  • College of Life Science and Technology, State Key Laboratory of Green Biomanufacturing, Innovation Center of Molecular Diagnostics, Beijing University of Chemical Technology, Beijing 100029, China.

ORCID-Profile: Zhao Yang

Förderung

  • Major Research Plan of the National Natural Science Foundation of China
  • National Key Research and Development Program
  • Open Competition to Select the Best Candidates" Key Technology Program for Nucleic Acid Drugs of NCTIB
  • Joint Project of Biomedical Translational Engineering Research Center of Beijing University of Chemical Technology-China-Japan Friendship Hospital
  • National Natural Science Foundation of China
  • Open Competition to Select the Best Candidates” Key Technology Program for Nucleic Acid Drugs of NCTIB
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Sabeel, Z., Chen, R., Liu, Y., Chen, X., Zhang, W., Pan, S., Ying, L., Yu, C., & Yang, Z. (2026). Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines. International Journal of Molecular Sciences, 27(7), 3251. https://doi.org/10.3390/ijms27073251

Vancouver

Sabeel Z, Chen R, Liu Y, Chen X, Zhang W, Pan S, et al. Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines. International Journal of Molecular Sciences. 2026;27(7):3251. doi:10.3390/ijms27073251

BibTeX
@article{Sabeel2026,
  author = {Sabeel, Zufa and Chen, Ruolan and Liu, Yan and Chen, Xiaoyang and Zhang, Wenjing and Pan, Shangyang and Ying, Lu and Yu, Changyuan and Yang, Zhao},
  title = {Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3251},
  doi = {10.3390/ijms27073251}
}
Kostenlos starten →